Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) Non Operating Income (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Non Operating Income for 6 consecutive years, with -$341687.0 as the latest value for Q4 2021.

  • Quarterly Non Operating Income fell 6394.72% to -$341687.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$41545.0 through Dec 2021, down 976.85% year-over-year, with the annual reading at -$1.3 million for FY2025, 83.02% down from the prior year.
  • Non Operating Income for Q4 2021 was -$341687.0 at ENDRA Life Sciences, down from -$7507.0 in the prior quarter.
  • The five-year high for Non Operating Income was $676842.0 in Q4 2019, with the low at -$773029.0 in Q3 2019.
  • Average Non Operating Income over 5 years is -$10117.5, with a median of -$2055.0 recorded in 2019.
  • Peak annual rise in Non Operating Income hit 18876.59% in 2018, while the deepest fall reached 19994.42% in 2018.
  • Over 5 years, Non Operating Income stood at $1931.0 in 2017, then skyrocketed by 18876.59% to $366438.0 in 2018, then skyrocketed by 84.71% to $676842.0 in 2019, then crashed by 100.78% to -$5261.0 in 2020, then plummeted by 6394.72% to -$341687.0 in 2021.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$341687.0, -$7507.0, and $1086.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.